Patent · US Active

Polymorph of a pharmaceutical

US8674112B2 · kind B2 · utility

1Cited by
13References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 2012
Grant dateMar 18, 2014
Priority date—
Expiry dateMay 25, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D277/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.